Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Seminars in Liver Disease · 2025-06 · 45 (02) · 210-220
DOI: 10.1055/a-2435-2091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 14.11.2024. Verfasst von Aurora Barberá und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Global NASH Council, Washington, District of Columbia. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and can progress to serious complications, including metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Predisposing risk factors for MASH include obesity, type 2 diabetes, dyslipidemia, and metabolic syndrome. Patients with MASH often experience significant impairments in their health-related quality of life and other patient-reported outcomes (PROs), particularly in physical functioning domains, fatigue, and vitality. Incorporating PROs offers valuable insights into patients' perspectives on their symptoms, treatment efficacy, and overall well-being, thereby guiding more holistic and patient-centered care strategies. This review aims to investigate the utilization of patient-reported outcome measures (PROMs) in the context of MASLD and MASH care, identify which PROMs are employed, and summarize the outcomes reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Global NASH Council, Washington, District of Columbia.
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
- Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia.
- CUNY Graduate School of Public Health and Health Policy, New York City, New York.
- Center for Outcomes Research in Liver Disease (CORLD), Washington, District of Columbia.
Zitieren
APA
Barberá, A., White, T. M., Arora, A. K., Henry, L., Lazarus, J. V., & Younossi, Z. M. (2025). Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease, 45(02), 210-220. https://doi.org/10.1055/a-2435-2091
Vancouver
Barberá A, White TM, Arora AK, Henry L, Lazarus JV, Younossi ZM. Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease. 2025;45(02):210-220. doi:10.1055/a-2435-2091
BibTeX
@article{Barber2025,
author = {Barberá, Aurora and White, Trenton M and Arora, Anish K and Henry, Linda and Lazarus, Jeffrey V and Younossi, Zobair M},
title = {Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {02},
pages = {210--220},
doi = {10.1055/a-2435-2091}
}
EUVIMED